Pyrrolopyridine derivatives as protein kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2608333

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the CDKs, Aurora, Jak2, Rock, CAMKII, FLT3, Tie2, TrkB, FGFR3 and KDR kinases.

L'invention concerne une nouvelle classe de composés, compositions pharmaceutiques comprenant de tels composés ainsi que des procédés d'utilisation pour traiter ou prévenir des maladies ou des troubles associés à l'activité anormale ou déréglée de la kinase, plus spécifiquement des maladies ou troubles mettant en oeuvre l'activation anormale de CDKs, Aurora, Jak2, Rock, CAMKII, FLT3, Tie2, TrkB, FGFR3 et KDR kinases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrolopyridine derivatives as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolopyridine derivatives as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyridine derivatives as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1914518

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.